全球基因分型市場規模、佔有率、成長分析，依類型（微陣列、聚合酶鍊式反應 (PCR)）、依應用（製藥和生物製藥公司、診斷實驗室和診所）- 2024-2031 年行業預測

Global Genotyping Market Size, Share, Growth Analysis, By Type(Microarray, Polymerase Chain Reaction (PCR)), By Application(Pharmaceutical and Biopharmaceutical Companies, Diagnostic Laboratories and Clinics) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球基因分型市場規模為214.3億美元，預計將從2023年的261.4億美元成長到2031年的1,283.1億美元，在預測期內（2024-2031年）複合年成長率為22%。

對基因檢測、個人化醫療和基因組學研究進展的日益成長的需求正在推動全球基因分型市場的強勁擴張。基因異常頻率的增加、早期疾病診斷知識的增加以及精準醫學的進步是推動市場發展的一些原因。在科學和治療領域，經常採用聚合酶鍊式反應 (PCR)、次世代定序 (NGS) 和微陣列等基因分型技術。此外，由於基因分型資料與資料分析和生物資訊技術的結合，市場正在擴大。為了在全球基因分型市場中獲得更大佔有率，該行業的主要競爭對手正在專注於產品創新、基因檢測產品多樣化以及建立策略聯盟。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Thermo Fisher Scientific Inc. (United States)
Illumina, Inc. (United States)
QIAGEN NV (Netherlands)
Agilent Technologies, Inc. (United States)
Bio-Rad Laboratories, Inc. (United States)
F. Hoffmann-La Roche Ltd (Switzerland)
Danaher Corporation (United States)
PerkinElmer, Inc. (United States)
Fluidigm Corporation (United States)
Eurofins Scientific (Luxembourg)
Luminex Corporation (United States)
Pacific Biosciences of California, Inc. (United States)
Oxford Nanopore Technologies Ltd. (United Kingdom)
Affymetrix, Inc. (United States)
Genewiz (United States)
GENEWIZ Germany GmbH (Germany)
Bioline Reagents Ltd. (United Kingdom)
Genomic Health, Inc. (United States)
Takara Bio Inc. (Japan)
Agena Bioscience, Inc. (United States)

簡介目錄

Product Code: SQMIG35D2088

Global Genotyping Market size was valued at USD 21.43 billion in 2022 and is poised to grow from USD 26.14 billion in 2023 to USD 128.31 billion by 2031, growing at a CAGR of 22% during the forecast period (2024-2031).

The increasing need for genetic testing, personalized medicine, and advances in genomics research are driving the robust expansion of the global genotyping market. Growing frequency of genetic abnormalities, increased knowledge of early illness diagnosis, and advancements in precision medicine are some of the reasons driving the market. In both scientific and therapeutic contexts, genotyping technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarrays are frequently employed. Furthermore, the market is expanding due to the incorporation of genotyping data with data analytics and bioinformatics technologies. To gain a bigger share of the worldwide genotyping market, major competitors in the industry are concentrating on product innovation, diversifying their genetic testing offerings, and forging strategic alliances.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genotyping Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genotyping Market Segmental Analysis

The Global Genotyping Market is segmented by type, application, and region. Based on type, the market can be segmented into microarray, polymerase chain reaction (pcr), sequencing, and others. Based on application, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic laboratories and clinics, research institutes and academic centers, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Genotyping Market

Growing need for customized treatment and the rising incidence of genetic disorders are two major factors propelling the worldwide genotyping industry. Finding genetic variants, mutations, and gene sequences that may be connected to certain illnesses or treatment reactions is made possible in large part by genotyping. Thanks to developments in genomics and our growing knowledge of genetic markers, genotyping now allows for individualized medication choices, diagnosis, and treatments. The growing need for precision medicine techniques and genotyping technologies is fueled by the increased frequency of hereditary illnesses.

Restraints in the Global Genotyping Market

The ethical and privacy issues surrounding genetic testing are a major barrier to the worldwide genotyping market. The availability of a person's genetic information gives rise to worries around potential abuse or misunderstanding of that information. The broad use of genotyping is hampered by concerns about permission, data security, and the possibility of discrimination based on genetic information. In addition, great thought must go into how genetic test findings are interpreted and shared with patients and medical professionals in order to guarantee correct comprehension and the right course of action. It is essential to address these privacy and ethical issues in order to foster involvement, foster confidence, and advance the responsible use of genotyping technology.

Market Trends of the Global Genotyping Market

The growing need for precision healthcare and tailored medication is a major trend in the worldwide genotyping market. In order to detect genetic variants and markers linked to different diseases and treatment responses, genotyping is essential. Researchers and healthcare professionals now have more access to genotyping thanks to advances in genomic technologies and genotyping's declining cost. Based on a person's genetic profile, genotyping enables customized treatment regimens that lead to more focused medicines, better disease management, and better patient outcomes. The potential for customized therapies and our increasing understanding of the genetic underpinnings of disease are what are driving this development. Healthcare is being revolutionized by genotyping because it allows for more targeted and efficient interventions based on each person's own genetic profile.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Genotyping Market by Type

Market Overview
Microarray
Polymerase Chain Reaction (PCR)
Sequencing
and Others

Global Genotyping Market by Application

Market Overview
Pharmaceutical and Biopharmaceutical Companies
Diagnostic Laboratories and Clinics
Research Institutes and Academic Centers
and Others

Global Genotyping Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GENEWIZ Germany GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioline Reagents Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomic Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agena Bioscience, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments